REG - OptiBiotix Health - Holding(s) in Company <Origin Href="QuoteRef">OPTIO.L</Origin>

OptiBiotix HealthAnnouncement

14/09/2016 16:40

RNS Number : 8694J
OptiBiotix Health PLC
14 September 2016
OptiBiotix Health plc
("OptiBiotix" or the "Company")
Holding in Company
The Company was informed on 13 September 2016 that Seneca Partners Limited no longer has a disclosable interest in the Company.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
For further information, please contact:
OptiBiotix Health plc
www.optibiotix.com
Stephen O'Hara, Chief Executive
Contact via Walbrook below


Cairn Financial Advisers LLP
 Tel: 020 7148 7900
Liam Murray



Hybridan LLP (Joint Broker)
Tel: 0203 764 2341
Claire Louise Noyce



Peterhouse Corporate Finance Ltd (Joint Broker)
Tel: 020 7469 0936
Lucy Williams / Duncan Vasey



Walbrook PR Ltd
Tel: 020 7933 8780 or optibiotix@walbrookpr.com
Anna Dunphy
Mob: 07876 741 001
About OptiBiotix - www.optibiotix.com 
OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease. 
The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human metabolic diseases, examples of which include obesity, cholesterol and lipid distribution and diabetes. 
OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression. The development pipeline is fuelled by its proprietary OptiScreen and OptiBiotic platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases. 

This information is provided by RNS
The company news service from the London Stock Exchange
  END
HOLGGUMWBUPQGAC